Jeevan Scientific Technology Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN L72200TG1999PLC031016 Incorporated 02 February 1999 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Listed - BSE: 538837 Public Limited Company pharma MSME · Small
Market Cap
₹173 Cr
JSTL · BSE
Share Price
₹87.00
+1.16% today
Revenue
₹61.54 Cr
FY 2025-26 · +31.4% YoY
EBITDA
₹9.80 Cr
Margin 15.9%
Net Profit
₹1.15 Cr
FY 2025-26 · +618.8% YoY
P/E (TTM)
25.3x
P/B 2.4x
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹20.08 Cr
Issued & subscribed

About Jeevan Scientific Technology Limited

Data last updated:

Jeevan Scientific Technology Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 02 February 1999 and has been in existence for over 27 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN L72200TG1999PLC031016. Its GSTIN is 36AAACJ8112F1ZV (Telangana). It is a listed company as per MCA records. Its shares are listed on BSE: 538837.

The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹20.08 Cr. It was formerly known as Jeevan Softech Limited and Jeevan Softech Private Limited. It is led by directors including Krishna Kishore Kuchipudi (Managing Director) and Nageswar Rao Yarllagadda (Whole-Time Director).

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Plot No. 1 & 2 Sai Krupa Enclave Manikonda Jagir Near Lanco Hills, Hyderabad, Telangana, India – 500008.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹61.54 Cr, a growth of 31.4% compared to the previous year. For the same year it recorded a net profit of ₹1.15 Cr (net margin 1.9%) and EBITDA of ₹9.8 Cr (EBITDA margin 15.9%).

The company has about 306 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 2 brands: Jeevan Climate and Jeevan Scientific Technology. As per MCA filings, the company has open charges of ₹27.86 Cr and satisfied charges of ₹19.2 Cr on record. The company has 10 deals on record (10 market trades); the latest was in October 2025. Its 3 peer companies in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities) are compared by revenue, 2 larger and 1 smaller; the largest is Alvogen Pharma (India) Private Limited with revenue of ₹51.32 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2020, listing 262 overdue payments to 19 micro and small suppliers.

Jeevan Scientific Technology Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0037959). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jeevanscientific.com.

Company details

CIN L72200TG1999PLC031016
Registration Number 031016
Incorporation Date 02 February 1999
ROC Hyderabad
Listing Status Listed - Listed on BSE (538837)
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0037959

Name history

Jeevan Scientific Technology has undergone 2 name changes throughout its history. The company was previously known as Jeevan Softech Limited, and Jeevan Softech Private Limited. The current legal name is Jeevan Scientific Technology Limited.

Company NameStatus
Jeevan Scientific Technology LimitedCurrent
Jeevan Softech LimitedPrevious
Jeevan Softech Private LimitedPrevious

CIN history

Jeevan Scientific Technology has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L72200TG1999PLC031016, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L72200TG1999PLC031016Current
L72200AP1999PLC031016Previous
U72200AP1999PLC031016Previous

Recognitions & Rankings of Jeevan Scientific Technology

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-TS-02-0037959

Contact details

Jeevan Scientific Technology Limited's registered office is in Hyderabad, Telangana. Its website is jeevanscientific.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Plot No. 1 & 2 Sai Krupa Enclave Manikonda Jagir Near Lanco Hills, Hyderabad, Telangana, India – 500008
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Jeevan Scientific Technology Limited, buy the company report.

Comprehensive company report
Jeevan Scientific Technology Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Jeevan Scientific Technology operates two associated brands: Jeevan Climate and Jeevan Scientific Technology. Each brand links to its own profile.

BrandDescriptionWebsite
Develops modular carbon capture systems using advanced resins for CO2 removal.jeevanclimate.com
Healthcare outsourcing services are provided by Jeevan Scientific Technology.jeevanscientific.com

Business activity

The main business activity of Jeevan Scientific Technology is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of Jeevan Scientific Technology Limited, buy the company report.

Financials of Jeevan Scientific Technology Limited

FY 2025-26 filings available

Jeevan Scientific Technology Limited reported revenue of ₹61.54 Cr (up 31.4% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹61.54 Cr
+31.4% YoY
EBITDA
₹9.80 Cr
+31.0% YoY
Profit After Tax
₹1.15 Cr
+618.8% YoY
Net Worth
-
Total Assets
-
Total Debt
-

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue61.5446.8439.6536.1867.7946.9523.94
Revenue growth+31.4%+18.1%+9.6%-46.6%+44.4%+96.1%-
EBITDA9.807.484.631.3516.7517.48(6.12)
EBITDA margin+15.9%+16.0%+11.7%+3.7%+24.7%+37.2%-25.6%
Profit before tax2.090.06(1.61)(3.69)18.0213.64(10.55)
Net profit1.150.16(1.30)(3.06)9.2611.73(8.56)
Net profit margin+1.9%+0.3%-3.3%-8.5%+13.7%+25.0%-35.8%
EPS (₹)0.610.08(0.84)(1.97)7.817.67(5.61)
Balance sheet
Total assets-71.2162.4558.8363.4045.6941.43
Net worth-49.9448.4348.1950.5835.0223.22
Total debt-20.5813.4110.1012.5510.3417.95
Cash & bank-0.240.546.8329.716.212.20
Net working capital-21.6719.2622.0939.9113.595.63
Cash flow
Cash from operations-10.072.89(6.41)19.564.95(0.01)
Cash from investing-(15.62)(11.53)(6.93)(1.20)(0.80)(1.90)
Cash from financing-5.242.35(9.54)5.67(0.13)0.44
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue23.1718.2821.2919.0712.388.8010.0612.51
Revenue growth (YoY)+87.2%+107.7%+111.6%+52.4%+8.6%-31.7%--
Other income0.440.170.290.140.200.330.150.23
EBITDA5.712.954.295.232.07(1.78)(0.38)2.08
EBITDA margin+24.6%+16.1%+20.2%+27.4%+16.7%-20.2%-3.8%+16.6%
Depreciation1.801.701.611.601.691.741.771.48
Interest0.480.440.410.540.550.540.550.43
Profit before tax3.870.982.563.230.03(3.73)(2.55)0.40
Tax0.970.110.730.830.02(0.51)(1.29)0.35
Net profit2.900.871.832.400.01(3.22)(1.26)0.05
EPS (₹)1.440.431.091.520.01(2.03)(0.79)0.03
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue53.9343.6138.5036.1856.5540.4720.57
Revenue growth+23.7%+13.3%+6.4%-36.0%+39.7%+96.7%-
EBITDA8.486.534.381.3517.0616.63(5.82)
EBITDA margin+15.7%+15.0%+11.4%+3.7%+30.2%+41.1%-28.3%
Profit before tax2.640.77(1.23)(3.62)18.3313.17(9.78)
Net profit1.650.73(1.05)(3.01)9.5411.25(7.79)
Net profit margin+3.1%+1.7%-2.7%-8.3%+16.9%+27.8%-37.9%
EPS (₹)0.980.46(0.68)(1.94)8.017.36(5.11)
Balance sheet
Total assets-64.3555.0257.4663.4046.9143.14
Net worth-50.9148.8048.3250.5836.2524.93
Total debt-12.885.808.8412.5510.3417.95
Cash & bank-0.210.516.1229.715.681.88
Net working capital-23.6419.3421.6539.9114.096.93
Cash flow
Cash from operations-2.962.74(6.29)19.564.73(1.19)
Cash from investing-(9.84)(4.69)(7.27)(1.20)(0.80)(1.02)
Cash from financing-6.58(3.66)(10.03)5.67(0.13)0.44
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue20.8716.9318.3816.9110.438.228.9211.87
Revenue growth (YoY)+100.1%+106.0%+106.1%+42.5%+1.3%-34.4%--
Other income0.560.260.370.180.260.380.140.22
Total expenses15.8013.2914.9012.268.969.339.839.83
EBITDA5.073.643.484.651.47(1.11)(0.91)2.04
EBITDA margin+24.3%+21.5%+18.9%+27.5%+14.1%-13.5%-10.2%+17.2%
Depreciation1.521.431.361.351.451.501.531.23
Interest0.350.300.250.380.380.360.350.26
Profit before tax3.762.172.243.10(0.10)(2.59)(2.65)0.77
Tax1.010.300.640.80(0.01)(0.43)(1.31)0.44

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 19 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue23.1718.2821.2919.0712.388.8010.0612.51
Revenue growth (YoY)+87.2%+107.7%+111.6%+52.4%+8.6%-31.7%--
Other income0.440.170.290.140.200.330.150.23
EBITDA5.712.954.295.232.07(1.78)(0.38)2.08
EBITDA margin+24.6%+16.1%+20.2%+27.4%+16.7%-20.2%-3.8%+16.6%
Depreciation1.801.701.611.601.691.741.771.48
Interest0.480.440.410.540.550.540.550.43
Profit before tax3.870.982.563.230.03(3.73)(2.55)0.40
Tax0.970.110.730.830.02(0.51)(1.29)0.35
Net profit2.900.871.832.400.01(3.22)(1.26)0.05
EPS (₹)1.440.431.091.520.01(2.03)(0.79)0.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue61.5446.8439.6536.1867.7946.9523.94
Revenue growth+31.4%+18.1%+9.6%-46.6%+44.4%+96.1%-
Other income0.970.650.671.075.922.392.53
Total expenses51.7439.3635.0234.8351.0429.4730.06
Employee cost0.0014.9013.2812.6218.1711.059.26
EBITDA9.807.484.631.3516.7517.48(6.12)
EBITDA margin+15.9%+16.0%+11.7%+3.7%+24.7%+37.2%-25.6%
Depreciation6.646.255.935.073.693.973.92
Interest2.041.820.981.040.962.263.04
Profit before tax2.090.06(1.61)(3.69)18.0213.64(10.55)
Tax1.06(0.01)(0.28)(0.61)6.091.91(1.96)
Net profit1.150.16(1.30)(3.06)9.2611.73(8.56)
Net profit margin+1.9%+0.3%-3.3%-8.5%+13.7%+25.0%-35.8%
EPS (₹)0.610.08(0.84)(1.97)7.817.67(5.61)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital-15.8315.4815.4815.3015.3015.30
Reserves & surplus-34.1132.9532.7135.2819.727.92
Shareholders' funds (net worth)-49.9448.4348.1950.5835.0223.22
Minority interest-0.130.200.230.000.000.00
Secured loans-14.309.715.154.2310.2910.58
Unsecured loans-6.283.704.958.320.057.37
Total debt-20.5813.4110.1012.5510.3417.95
Total liabilities-71.2162.4558.8363.4045.6941.43
Assets
Gross block-74.7460.2152.3340.8545.3944.75
Net block-34.5426.6724.9819.0727.3730.54
Capital work in progress-4.712.811.900.000.000.00
Investments-0.000.000.000.000.000.00
Inventories-1.621.090.871.463.460.95
Sundry debtors-15.9412.2911.687.6114.456.84
Cash & bank balances-0.240.546.8329.716.212.20
Loans & advances-10.9510.759.8015.119.768.09
Total current assets-28.7524.6729.1853.8933.8818.08
Total current liabilities-7.085.417.0913.9820.2912.45
Net working capital-21.6719.2622.0939.9113.595.63
Total assets-71.2162.4558.8363.4045.6941.43
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash-0.546.8329.715.682.203.67
Net cash from operating activities-10.072.89(6.41)19.564.95(0.01)
Net cash from investing activities-(15.62)(11.53)(6.93)(1.20)(0.80)(1.90)
Net cash from financing activities-5.242.35(9.54)5.67(0.13)0.44
Net change in cash-(0.30)(6.29)(22.88)24.034.02(1.47)
Closing cash-0.240.546.8329.716.212.20
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+31.4%+18.1%+9.6%-46.6%+44.4%+96.1%-
EBITDA growth+31.0%+61.6%+243.0%-91.9%-4.2%+385.6%-
PBT growth+3383.3%+9998.0%+56.4%-+32.1%+9998.0%-
Net income growth+618.8%+112.3%+57.5%-133.1%-21.1%+237.0%-
Revenue CAGR (3Y)+19.4%-11.6%-5.5%+14.8%+37.4%+32.0%+9.6%
EBITDA CAGR (3Y)+93.6%-23.6%-35.8%-+42.0%+72.1%-
Profitability & leverage
Net income margin+1.7%+0.2%-3.4%-8.5%+17.6%+25.0%-35.9%
Return on capital employed-+2.8%-1.0%-4.3%+27.4%+36.5%0.0%
Return on net worth-+0.1%-2.8%-6.2%+21.7%+40.3%0.0%
Debt / equity-0.350.240.230.270.490.66
Long-term debt / equity-0.260.160.100.140.270.28
Interest cover64.56147.97-75.38-27.967.3516.73-30.28
Efficiency & per share
Fixed asset turnover-0.690.700.781.571.040.55
Inventory turnover-34.5740.4631.0627.5621.2940.58
Debtors turnover-3.323.313.756.154.412.22
EPS (₹)0.610.08(0.84)(1.97)7.817.67(5.61)
Dividend per share (₹)0.000.000.000.001.200.500.00
Book value per share (₹)0.0031.5431.2831.1333.0622.8915.18
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue20.8716.9318.3816.9110.438.228.9211.87
Revenue growth (YoY)+100.1%+106.0%+106.1%+42.5%+1.3%-34.4%--
Other income0.560.260.370.180.260.380.140.22
Total expenses15.8013.2914.9012.268.969.339.839.83
EBITDA5.073.643.484.651.47(1.11)(0.91)2.04
EBITDA margin+24.3%+21.5%+18.9%+27.5%+14.1%-13.5%-10.2%+17.2%
Depreciation1.521.431.361.351.451.501.531.23
Interest0.350.300.250.380.380.360.350.26
Profit before tax3.762.172.243.10(0.10)(2.59)(2.65)0.77
Tax1.010.300.640.80(0.01)(0.43)(1.31)0.44
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue53.9343.6138.5036.1856.5540.4720.57
Revenue growth+23.7%+13.3%+6.4%-36.0%+39.7%+96.7%-
Other income1.190.630.691.065.912.382.52
Total expenses45.4537.0834.1234.8339.4923.8426.39
Employee cost0.0013.6212.9312.6213.168.007.13
EBITDA8.486.534.381.3517.0616.63(5.82)
EBITDA margin+15.7%+15.0%+11.4%+3.7%+30.2%+41.1%-28.3%
Depreciation5.655.295.555.023.683.963.91
Interest1.381.100.751.010.961.882.57
Profit before tax2.640.77(1.23)(3.62)18.3313.17(9.78)
Tax0.990.03(0.18)(0.61)6.091.92(1.96)
Net profit1.650.73(1.05)(3.01)9.5411.25(7.79)
Net profit margin+3.1%+1.7%-2.7%-8.3%+16.9%+27.8%-37.9%
EPS (₹)0.980.46(0.68)(1.94)8.017.36(5.11)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital-15.8315.4815.4815.3015.3015.30
Reserves & surplus-35.0833.3232.8435.2820.959.63
Shareholders' funds (net worth)-50.9148.8048.3250.5836.2524.93
Secured loans-7.683.434.854.2310.2910.58
Unsecured loans-5.202.373.998.320.057.37
Total debt-12.885.808.8412.5510.3417.95
Total liabilities-64.3555.0257.4663.4046.9143.14
Assets
Gross block-67.5253.3151.3340.8538.5137.71
Net block-28.7220.2024.0319.0720.5323.68
Capital work in progress-0.000.000.000.000.000.00
Investments-2.002.002.000.001.031.03
Inventories-0.931.010.871.464.940.95
Sundry debtors-14.3911.9311.687.6112.466.00
Cash & bank balances-0.210.516.1229.715.681.88
Loans & advances-14.3810.789.2715.117.877.85
Total current assets-29.9124.2327.9453.8930.9516.68
Total current liabilities-6.274.896.2913.9816.869.75
Net working capital-23.6419.3421.6539.9114.096.93
Total assets-64.3555.0257.4663.4046.9143.14
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash-0.516.1229.715.681.883.66
Net cash from operating activities-2.962.74(6.29)19.564.73(1.19)
Net cash from investing activities-(9.84)(4.69)(7.27)(1.20)(0.80)(1.02)
Net cash from financing activities-6.58(3.66)(10.03)5.67(0.13)0.44
Net change in cash-(0.30)(5.61)(23.59)24.033.80(1.77)
Closing cash-0.210.516.1229.715.681.88
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+23.7%+13.3%+6.4%-36.0%+39.7%+96.7%-
EBITDA growth+29.9%+49.1%+224.4%-92.1%+2.6%+385.7%-
PBT growth+242.9%+9998.0%+66.0%-+39.2%+9998.0%-
Net income growth+126.0%+169.5%+65.1%-131.6%-15.2%+244.4%-
Revenue CAGR (3Y)+14.2%-8.3%-1.7%+20.7%+30.5%+28.1%+5.6%
EBITDA CAGR (3Y)+84.5%-27.4%-35.9%-+43.1%+71.1%-
Profitability & leverage
Net income margin+3.1%+1.7%-2.7%-8.3%+21.6%+27.8%-38.0%
Return on capital employed-+3.1%-0.9%-4.3%+27.7%+33.4%0.0%
Return on net worth-+1.5%-2.2%-6.1%+22.0%+36.8%0.0%
Debt / equity-0.190.150.220.260.460.63
Long-term debt / equity-0.120.070.090.140.260.27
Interest cover48.7688.71-64.10-27.527.1714.84-26.41
Efficiency & per share
Fixed asset turnover-0.720.740.781.431.060.55
Inventory turnover-44.9640.9631.0617.6713.7434.86
Debtors turnover-3.313.263.755.644.382.01
EPS (₹)0.980.46(0.68)(1.94)8.017.36(5.11)
Dividend per share (₹)0.000.000.000.001.200.500.00
Book value per share (₹)0.0032.1631.5331.2133.0623.6916.29

To see the full year-wise statements and ratios of Jeevan Scientific Technology Limited, buy the company report.

Board of directors of Jeevan Scientific Technology Limited

Jeevan Scientific Technology has 8 current directors and 25 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jeevan Krishna KuchipudiDirector02 Nov 20206 Years 0 MonthsCurrent
Nageswar Rao YarllagaddaWhole-Time Director23 Jun 20215 Years 4 MonthsCurrent
Snigdha MothukuriWhole-Time Director02 Nov 20206 Years 0 MonthsCurrent
Venkata Subba Rao GuttikondaDirector25 Mar 20224 Years 7 MonthsCurrent
Krishna Kishore KuchipudiManaging Director02 Feb 199927 Years 9 MonthsCurrent
Suryaprakasa Rao BommisettiDirector25 Mar 20224 Years 7 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer comparison

Jeevan Scientific Technology Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Jeevan Scientific Technology Limitedthis company₹61.54 Cr (FY 2026)₹1.15 Cr1.9%31.4%306Hyderabad, Telangana, India
Alvogen Pharma (India) Private Limited₹51.32 Cr (FY 2025)-6.0%Bangalore, Karnataka, India
Allucent (India) Private Limited₹47.87 Cr (FY 2025)4.0%Bangalore, Karnataka, India
Emerald Clinical Trials India Private Limited₹46.42 Cr (FY 2025)-28.0%Bangalore, Karnataka, India

To see the full peer comparison of Jeevan Scientific Technology Limited, buy the company report.

Auditor

Jeevan Scientific Technology Limited is audited by PALAVURI & Co. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
PALAVURI & Co.FY 2024012194S

Shareholding

Shareholding for the quarter ended Mar 2026: promoters hold 30.20%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 69.80%.

Promoters: 30.20%Retail & Others: 69.80%
Mar 2026
QUARTER
30.20% Promoters
69.80% Retail & Others
Promoter holding - history
Now 30.20% · Mar 2026High 38.00% · Jun 2025Low 30.20% · Mar 2026
29%31.5%34%36.5%39%Jun 2025Sep 2025Dec 2025Mar 2026Jun 2025: 38.00%Sep 2025: 38.00%Dec 2025: 38.00%Mar 2026: 30.20%38.00%30.20%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025
Promoters30.20%38.00%38.00%38.00%
Public69.80%62.00%62.00%62.00%

Charges & borrowings

Open charges
₹27.86 Cr
Satisfied charges
₹19.2 Cr
Breakdown by lending institutions
Others₹27.56 Cr
Hdfc Bank Limited₹0.30 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Apr 2026101289492Others₹40 LakhOpen
29 Jan 2026101244909Others₹2.55 CrOpen
22 Jan 2025101074475Others₹81 LakhOpen
28 Aug 2024100992019Others₹4.2 CrOpen
29 Jul 2024100990450Others₹95.15 LakhOpen

To see the full charge records of Jeevan Scientific Technology Limited, buy the company report.

Total charge records: 15 View all charges

Deals & funding

Jeevan Scientific Technology Limited has 10 deals on record (10 market trades); the latest was in October 2025.

Total deals
10
Market trades
10

Deals on record (5 of 10)

WhenDealAmountParties
Oct 2025Market trade₹2.61 CrBuyer: Rampurhat PSC Sleepers Limited , an individual
Seller: an individual
Oct 2025Market trade₹2.51 CrBuyer: Rampurhat PSC Sleepers Limited , 2 individuals
Seller: an individual
Jun 2021Market trade₹1.39 CrBuyer: an individual
Jun 2021Market trade₹1.53 CrBuyer: Alpha Leon Enterprises LLP
Seller: Alpha Leon Enterprises LLP
Mar 2016Market trade₹29.2 LakhBuyer: Rajasthan Global Securities Private Limited
Seller: an individual

To see the full deal history of Jeevan Scientific Technology Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Jeevan Scientific Technology Limited has 5 MSME Form 1 returns on record between 2019 and 2020, listing 262 overdue payments to 19 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 19)

SupplierAmount dueDue sinceReported on
Bioorganics and Applied Materials Private Limited
Bharat Science Appparatus Workshops
Smart Labtech Private Limited
an individual supplier
Mokshy Surgicals

To see the full MSME payment records of Jeevan Scientific Technology Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Jeevan Scientific Technology has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Nayas Laboratories Private LimitedU24290TG2022PTC167401

To see the full group structure of Jeevan Scientific Technology Limited, buy the company report.

Employees & EPFO

Jeevan Scientific Technology Limited has a workforce of 306 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
306
Active EPFO establishments
1
Employee growth
19.5%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27306
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Jeevan Scientific Technology Limited, buy the company report.

GST

Jeevan Scientific Technology has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAACJ8112F1ZVTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Jeevan Scientific Technology Limited, buy the company report.

Recent activity

Jeevan Scientific Technology Limited has 43 board changes on record since 1999: 26 appointments and 17 cessations. The latest: Bhanu Prakash Gali ceased to be Director on 29 Sep 2025.

Charges
A charge with Others amounted to Rs. 0.40 Cr with Charge ID 101289492 was registered on 20 Apr 2026.
Filing
Jeevan Scientific Technology Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 2.55 Cr with Charge ID 101244909 was registered on 29 Jan 2026.
Ceased
Bhanu Prakash Gali ceased to be Director.
AGM
Jeevan Scientific Technology Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Appointed
Gollapinwi Mallikarjuna was appointed as Director.
Ceased
Thammareddy Ravi ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.81 Cr with Charge ID 101074475 was registered on 22 Jan 2025.
Charges
A charge registered on 28 Oct 2020 via Charge ID 100387794 with Others was fully satisfied on 08 Jan 2025.
Charges
A charge with Others of Rs. 18.65 Cr registered on 26 Mar 2010 with Charge ID 10216481 was modified on 20 Dec 2024.
Charges
A charge registered on 23 Sep 2024 via Charge ID 100991959 with Others was fully satisfied on 12 Dec 2024.
Appointed
Srinivas Reddy Maram was appointed as CEO.

58 earlier events are in the company report.

Frequently asked questions

Jeevan Scientific Technology is an active public limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 02 February 1999 (27+ years old) and is registered under CIN L72200TG1999PLC031016. Listed on BSE: 538837.

Jeevan Scientific Technology reported revenue of ₹61.54 Cr for FY 2025-26 (up 31.4% YoY) based on consolidated financials.

Jeevan Scientific Technology has 8 current directors:

The latest financial statements of Jeevan Scientific Technology on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Jeevan Scientific Technology is 36AAACJ8112F1ZV, registered in Telangana.

The CIN (Corporate Identification Number) of Jeevan Scientific Technology is L72200TG1999PLC031016. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Jeevan Scientific Technology is a listed company as per MCA records. Its shares are listed on BSE (code: 538837).

Jeevan Scientific Technology was incorporated on 02 February 1999, making it 27+ years old. It is registered with the Registrar of Companies, Hyderabad.

Jeevan Scientific Technology has 10 deals on record (10 market trades); the latest was in October 2025.

The peers of Jeevan Scientific Technology by revenue are Alvogen Pharma (India) Private Limited, Allucent (India) Private Limited, Emerald Clinical Trials India Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities).

Bhanu Prakash Gali ceased to be Director on 29 Sep 2025. Gollapinwi Mallikarjuna was appointed as Director on 14 Aug 2025. Thammareddy Ravi ceased to be Director on 14 Aug 2025. Jeevan Scientific Technology has 43 board changes on record in total.

Yes, Jeevan Scientific Technology is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0037959).